Study of a new medicine called SNH-119014 in healthy volunteers
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial tests a new drug called SNH-119014 for the first time in humans. It involves healthy volunteers to check the drug's safety and how the body processes it. It may be a step toward a new treatment for certain conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy man or woman aged 18–45.
- You weigh at least 50 kg (men) or 45 kg (women), with a body mass index (BMI) between 18.5 and 28.
- You do not have any major medical conditions like heart, liver, kidney, or other organ problems.
- You are not taking any prescription or over-the-counter drugs, herbs, or supplements for two weeks before the study.
- You do not smoke more than 5 cigarettes a day and can avoid smoking during the study.
- You agree to use birth control and not donate sperm or eggs during and for 3 months after the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug called ISH0613 in healthy volunteers to see if it is safe and how the body processes it. It is the first time this drug is given to humans.
This study tests an investigational oral medication (SNH-119014) in adults with non-transfusion-dependent thalassemia, which means they have anemia but don't need regular transfusions. It aims to see if the drug can safely help increase hemoglobin levels and improve symptoms.
This study tests a new medicine called HL-1186 in healthy volunteers to see how safe it is and how the body handles it. If you join, you will help researchers gather early information that may lead to future treatments.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.
Hear when a new Hemoglobinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.